Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential of neuromelanin-sensitive MRI in psychiatric disorders. | Neurosci Appl | 2026 | 41809677 | PubTator, text mining | PubMed |
| Expanding the Genotypic Spectrum of SLC18A2 Mutation-Related Disorder-A Novel Mutation and Review of Literature. | J Child Neurol | 2026 | 41804711 | PubTator, text mining | PubMed |
| Diabetic Striatopathy in an Elderly Female With Poorly Controlled Type 2 Diabetes: A Case Report. | Clin Case Rep | 2026 | 41804471 | PubTator, text mining | PubMed |
| Methylglyoxal Affects Dopamine Homeostasis in SH-SY5Y Cells Through the Modulation of miR-190a and miR-214. | FASEB J | 2026 | 41793170 | PubTator, text mining | PubMed |
| Reversible aripiprazole-induced tardive dyskinesia: a case series from Saudi Arabia and literature review. | Front Psychiatry | 2026 | 41788644 | PubTator, text mining | PubMed |
| Disruption of Dopamine Homeostasis by Psychostimulants. | Mol Neurobiol | 2026 | 41784673 | PubTator, text mining | PubMed |
| Synaptic Chaperone Dysfunction as a Convergent Mechanism in Neurodegenerative and Psychiatric Disorders. | Neurosci Insights | 2026 | 41783689 | PubTator, text mining | PubMed |
| Deutetrabenazine and Modified Electroconvulsive Therapy for Tardive Dyskinesia With Recurrent Depression: A Case Report. | Cureus | 2026 | 41782784 | PubTator, text mining | PubMed |
| Update on the Pathophysiology and Management of Tics. | Curr Neurol Neurosci Rep | 2026 | 41779259 | PubTator, text mining | PubMed |
| Environmental Substances Associated with Neurodegeneration: An Overview of Parkinson's Disease and Related Genotoxic Endpoints. | Genes (Basel) | 2026 | 41751620 | PubTator, text mining | PubMed |
| Polychlorinated Biphenyls, Oxidative Stress, and Brain Health: Mechanistic Links to Neurodegenerative and Neurodevelopmental Diseases. | Antioxidants (Basel) | 2026 | 41750622 | PubTator, text mining | PubMed |
| Expression and Diagnostic Significance of Clinical Routine VMAT2 Immunostaining in Neuroendocrine Neoplasia: A Study of Institutional Cases. | J Histochem Cytochem | 2026 | 41731695 | PubTator, text mining | PubMed |
| Structure-activity landscape of Nurr1 (NR4A2) modulators: medicinal chemistry strategies for neurodegenerative disease intervention. | RSC Med Chem | 2026 | 41727529 | PubTator, text mining | PubMed |
| A Machine Learning-Guided Approach for Identifying Potential HCAR1 Antagonists in Lactate-Driven Cancers. | ACS Omega | 2026 | 41726659 | PubTator, text mining | PubMed |
| DeepRetro discovers retrosynthetic pathways through iterative large language model reasoning. | Sci Rep | 2026 | 41680415 | PubTator, text mining | PubMed |
| VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1-linked Parkinson's neurons. | Sci Adv | 2026 | 41671379 | PubTator, text mining | PubMed |
| Safety and efficacy of VMAT2 inhibitors in Huntington Disease: A systematic review. | Parkinsonism Relat Disord | 2026 | 41651710 | PubTator, text mining | PubMed |
| An in vivo and in vitro spatiotemporal profile of human midbrain development. | Nat Commun | 2026 | 41633979 | PubTator, text mining | PubMed |
| Neuropeptide S Protects Dopaminergic Neurons in a Paraquat-Induced Parkinson's Model Using SH-SY5Y Cells. | Mol Neurobiol | 2026 | 41627613 | PubTator, text mining | PubMed |
| The Use of VMAT2 Inhibitors for Tardive Dyskinesia. | J Clin Psychopharmacol | 2026 | 41626799 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=3